{rfName}
Tr

Indexado en

Licencia y uso

Altmetrics

Análisis de autorías institucional

Calleja, JlAutor o CoautorBellas, CAutor o Coautor

Compartir

Publicaciones
>
Artículo

Treatment of low-grade gastric MALT lymphoma with Helicobacter pylori eradication. Follow-up of the histological and molecular response [Tratamiento del linfoma gástrico MALT de bajo grado con erradicación de Helicobacter pylori. Seguimiento de la respues

Publicado en:MEDICINA CLINICA. 110 (2): 41-44 - 1998-01-24 110(2), DOI:

Autores: Montalban, C; Manzanal, A; Boixeda, D; Redondo, C; Alvarez, I; Frutos, B; Calleja, JL; Sanchez-Godoy, P; Bellas, C

Afiliaciones

Serv. de Anat. Patológica, Hospital Ramón y Cajal, Madrid, Spain - Autor o Coautor
Servicio de Gastroenterología, Hospital Ramón y Cajal, Madrid, Spain - Autor o Coautor
Servicio de Hematología, Hospital Severo Ochoa, Leganés, Madrid, Spain - Autor o Coautor
Servicio de Medicina Interna, Hospital Ramón y Cajal, Carretera de Colmenar, km 9, 28043 Madrid, Spain - Autor o Coautor
Servicio de Medicina Interna, Hospital Ramón Y Cajal, Madrid, Spain - Autor o Coautor
Ver más

Resumen

Low grade gastric MALT lymphoma is associated to infection with Helicobacter pylori. Also, H. pylori eradication can produce histologic regression of the lymphoma.This study reports the follow-up of a prospective series of 11 patients with low grade gastric MALT lymphoma, stage I, treated with eradicative therapy for H. pylori. After treatment, patients were followed up with sequential endoscopies to asses the histological and molecular regression of the lymphoma, using a score of the histological lesions and the amplification of the IgH gene with PCR analysis.Helicobacter pylori was eradicated in all patients. In 10(90.9%) histological regression of the lymphoma was demonstrated, in 6 of them in the first control after treatment. In the 10 patients with histological response, PCR analysis demonstrated a polyclonal rearrangement of the IgH gene in 6 (60%) and a clonal band in 4 (40%), that eventually disappeared at 12 (SD 4) months after treatment. In 4 patients with a previous polyclonal rearrangement, a clonal band was occasionally detected in any sequential controls; in 2 of these cases the clonal band disappeared 5 and 7 months after treatment and in the remaining 2 its evolution is not yet known. Nine patients have been followed up and are in remission 18 (SD 8) months after treatment.Eradication of H. pylori can produce histologic regression in stage I low grade gastric MALT lymphoma, and should be the first therapeutic option. Despite histological regression of the lymphoma, PCR analysis can detect a clonal rearrangement of the IgH gene in 40% of the cases, but its significance remains unknown. Sequential and prolonged follow-up is essential to assess whether this lymphoma can be actually cured with eradication therapy for H. pylori.

Palabras clave

AdultAgedAnti-bacterial agentsAntiinfective agentArticleFemaleFollow upFollow-up studiesGene rearrangementGeneticsHelicobacter infectionHelicobacter infectionsHelicobacter pyloriHumanHumansImmunoglobulin heavy chainImmunoglobulin heavy chainsLymphoma, mucosa-associated lymphoid tissueMaleMicrobiologyMiddle agedMucosa associated lymphoid tissue lymphomaPathologyPathophysiologyPolymerase chain reactionProspective studiesProspective studyRemissionRemission inductionStomach neoplasmsStomach tumor

Indicios de calidad

Impacto bibliométrico. Análisis de la aportación y canal de difusión

El trabajo ha sido publicado en la revista MEDICINA CLINICA debido a la progresión y el buen impacto que ha alcanzado en los últimos años, según la agencia Scopus (SJR), se ha convertido en una referencia en su campo. En el año de publicación del trabajo, 1998, se encontraba en la posición , consiguiendo con ello situarse como revista Q1 (Primer Cuartil), en la categoría .

2025-06-28:

  • WoS: 8
  • Europe PMC: 9

Análisis de liderazgo de los autores institucionales

Existe un liderazgo significativo ya que algunos de los autores pertenecientes a la institución aparecen como primer o último firmante, se puede apreciar en el detalle: Último Autor (BELLAS MENENDEZ, CARMEN).